Taryao, Renante Y.
HRN: 24-07-93 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/12/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/12/2023
11/19/2023
IV
500
Q8
Multiple STI Sec To MVA
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft TissueProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes